CompletedPhase 1NCT04529538

Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
PATH
Principal Investigator
Jessica Crothers, MD
University of Vermont
Intervention
Novel Oral Polio Vaccine Type 1 (nOPV1)(biological)
Enrollment
226 target
Eligibility
18-45 years · All sexes
Timeline
20212023

Study locations (4)

Collaborators

Bill and Melinda Gates Foundation · Centers for Disease Control and Prevention · Viroclinics Biosciences B.V. · The Emmes Company, LLC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04529538 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials